European Hematology Association: A New Anti-CD22 CAR-T Immunotherapy Saved Life of Children ...

02:30 EDT 16 Jun 2018 | BioMedReports - Blog

B acute lymphoblastic leukemia (B-ALL) is a fatal blood cell tumor that is usually treated with chemotherapy or allogeneic hematopoietic stem cell transplantation (allo-HCT), and

More From BioPortfolio on "European Hematology Association: A New Anti-CD22 CAR-T Immunotherapy Saved Life of Children ..."